Patents expiring in 2035

US 9068002

Treatment of multiple sclerosis and/or rheumatoid arthritis

Universität Regensburg · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067968

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068185

Antisense modulation of nuclear hormone receptors

Sarepta Therapeutics, Inc. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066855

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068007

Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

The Board of Regents of the University of Texas System · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068014

Colon and pancreas cancer peptidomimetics

PRECISION BIOLOGICS, INC. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066900

Interferon-β production modulating listeria strains and methods for using same

The Regents of the University of California · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067961

Thiocarbon-protecting groups for RNA synthesis

The Regents of the University of Colorado Denver · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067891

1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors

Addex Pharma, S.A. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067962

Methods of treating diabetes

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066907

Methods for treating burns-related systemic inflammatory response syndrome

Biofunctional Structure Research Institute, BFSR Co. Ltd. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066965

Purified limonin glucoside for prevention and treatment of chronic diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067925

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066967

Oligonucleotide analogues targeting human LMNA

Sarepta Therapeutics, Inc. · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066904

Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

YOUNG LIVING ESSENTIAL OILS, LC · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066944

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066943

Use of botulinum toxin therapy for treatment of urological neurological conditions

The Regents of the University of Colorado · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066948

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066883

Administration of cells and cellular extracts for rejuvenation

REGENICS AS · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068165

Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068003

Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067989

Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066982

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9067932

Pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2933552

ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS

ALK-ABELLO AS [DK] · Granted Thu Jul 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072789

Nano-particle surface modification

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072742

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072765

Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072709

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072732

Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease

The Regents of the University of California · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072705

Oligo-benzamide compounds and their use in treating cancers

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072710

Injectable ibuprofen formulation

Cumberland Pharmaceuticals Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072675

Non-irritating benzoyl peroxide

Essential Ingredients, Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072661

Injectable ibuprofen formulation

Cumberland Pharmaceuticals Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072752

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9073864

Aromatic ring compound

Takeda Pharmaceutical Company Limited · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072770

Aqueous extracts of Anoectochilus spp. kinsenoside and pharmaceutical compositions useful for hepatoprotection

China Medical University · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9073851

Compositions and methods for treating cancer

The Board of Regents of the University of Texas System · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072763

Methods and compositions for treating inflammatory bowel disease

RedHill Biopharma Ltd. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9073859

Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound

Theravance Biopharma R&D IP, LLC · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074254

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9073863

Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof

The Regents of the University of California · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074255

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074256

Method of predicting a predisposition to QT prolongation

VANDA PHARMACEUTICALS INC. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074213

Compositions and methods for inhibiting expression of a target gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074212

RNAi inhibition of alpha-ENaC expression

Arrowhead Research Corporation · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074195

Nanoparticle entrapment of materials

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9073989

Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof

PROTEIN DESIGN LAB, LTD. · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)